Block of gold rock isolated on white
Source: Adobe Stock.
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Emerald Resources (ASX:EMR) has reportedly seen 28,539 ounces of gold extracted from its Okvau gold mine in Cambodia during the March 2024 quarter.

This follows a successful six-month period ending December 2023, during which the company produced a total of 85,831 ounces of gold, which kept it on track to meet its production targets for the fiscal year 2024.

The Okvau gold mine performed exceptionally well during the March 2024 quarter – it exceeded the upper end of the production guidance range of 25,000 to 30,000 ounces per quarter. Additionally, the mine poured over 10,000 kilograms of gold doré – which reflects its output capacity.

Gold sales for the quarter totaled 28,494 ounces – at an average price of US$2,069 per ounce. The company reported a strong financial position with A$137.4 million (US$89.8 million) in cash and bullion on hand at the end of the quarter, even after settling year-end tax payments and acquisition duties.

Emerald Resources also noted that the all-in sustaining cost (AISC) for the March 2024 quarter remained consistent with previous guidance.

The company will provide a comprehensive update on its operations and exploration activities in the upcoming March 2024 Quarterly Report – which is set for release later this month.

EMR is up 2.7 per cent on the news, and has been trading at $3.39.

EMR by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…